Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francine Kay Welty, Ph.D., M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Effect of Soy Phytoestrogens and Low-Dose Estrogens on Lipid Levels, Brachial Artery Function, and Biochemical Markers of Bone Turnover in Postmenopausal Women
Full Time/Year Long, 07/05/00 - 06/29/01
Soy in Postmenopausal Women
Part Time/Continuation, 10/20/00 - 12/31/00
Phytoestrogens and Low-Dose Estrogen in Postmenopausal Women
Part Time, 03/20/00 - 06/16/00

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DE018184 (WELTY, FRANCINE K) Aug 10, 2007 - Jul 31, 2014
    NIH/NIDCR
    Periodontal Disease and Coronary Artery Remodeling in CHD and Metabolic Syndrome
    Role: Principal Investigator
  2. P50HL083813 (WELTY, FRANCINE K) May 1, 2006 - Mar 31, 2015
    NIH/NHLBI
    Metabolic Syndrome, Inflammation and Vascular Remodeling
    Role: Principal Investigator
  3. K07DK002974 (WELTY, FRANCINE K) Sep 1, 2000 - Aug 31, 2007
    NIH/NIDDK
    TEACHING NUTRITION TO PREVENT CARDIOVASCULAR DISEASES
    Role: Principal Investigator
  4. R01HL056895 (WELTY, FRANCINE K) Aug 15, 1997 - Jun 30, 2009
    NIH/NHLBI
    ApoB and ApoA-I Kinetics in the ApoB-67 Mutation
    Role: Principal Investigator
  5. R29HL056895 (WELTY, FRANCINE K) Aug 15, 1997 - Jun 30, 2001
    NIH/NHLBI
    MECHANISMS OF LOW LEVELS OF APOLIPOPROTEIN B
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Welty FK. Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk. Curr Opin Lipidol. 2020 Aug; 31(4):206-231. PMID: 32692035.
    Citations:    
  2. Coussa-Koniski ML, Saliba E, Welty FK, Deeb M. Epidemiological characteristics of obstructive sleep apnea in a hospital-based historical cohort in Lebanon. PLoS One. 2020; 15(5):e0231528. PMID: 32413035.
    Citations:    
  3. Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, Kosiborod M, Leiter LA, Lipska KJ, Newman JD, Welty FK. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation. 2020 May 12; 141(19):e779-e806. PMID: 32279539.
    Citations:    
  4. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. Curr Opin Lipidol. 2020 Apr; 31(2):49-55. PMID: 32039990.
    Citations:    
  5. Malik A, Kanduri JS, Asbeutah AAA, Khraishah H, Shen C, Welty FK. Exercise Capacity, Coronary Artery Fatty Plaque, Coronary Calcium Score, and Cardiovascular Events in Subjects With Stable Coronary Artery Disease. J Am Heart Assoc. 2020 Apr 07; 9(7):e014919. PMID: 32212910.
    Citations:    
  6. Jelwan YA, Asbeutah AAA, Welty FK. Comprehensive Review of Cardiovascular Diseases, Diabetes, and Hypercholesterolemia in Lebanon. Cardiol Rev. 2020 Mar/Apr; 28(2):73-83. PMID: 31985525.
    Citations:    
  7. Nanna MG, Hajduk AM, Krumholz HM, Murphy TE, Dreyer RP, Alexander KP, Geda M, Tsang S, Welty FK, Safdar B, Lakshminarayan DK, Chaudhry SI, Dodson JA. Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study. Circ Cardiovasc Qual Outcomes. 2019 10; 12(10):e005691. PMID: 31607145.
    Citations:    
  8. Skulas-Ray AC, Wilson PWF, Harris WS, Brinton EA, Kris-Etherton PM, Richter CK, Jacobson TA, Engler MB, Miller M, Robinson JG, Blum CB, Rodriguez-Leyva D, de Ferranti SD, Welty FK. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. Circulation. 2019 09 17; 140(12):e673-e691. PMID: 31422671.
    Citations:    
  9. Pallazola VA, Davis DM, Whelton SP, Cardoso R, Latina JM, Michos ED, Sarkar S, Blumenthal RS, Arnett DK, Stone NJ, Welty FK. A Clinician's Guide to Healthy Eating for Cardiovascular Disease Prevention. Mayo Clin Proc Innov Qual Outcomes. 2019 Sep; 3(3):251-267. PMID: 31485563.
    Citations:    
  10. Alfaddagh A, Elajami TK, Saleh M, Mohebali D, Bistrian BR, Welty FK. An omega-3 fatty acid plasma index =4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment. Atherosclerosis. 2019 06; 285:153-162. PMID: 31055222.
    Citations:    
  11. Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2019 02; 39(2):e38-e81. PMID: 30580575.
    Citations:    Fields:    
  12. Welty FK. New Areas of Interest: Is There a Role for Omega-3 Fatty Acid Supplementation in Patients With Diabetes and Cardiovascular Disease? Curr Diab Rep. 2019 01 25; 19(2):6. PMID: 30684085.
    Citations:    Fields:    
  13. Saleh M, Alfaddagh A, Elajami TK, Ashfaque H, Haj-Ibrahim H, Welty FK. Diastolic blood pressure predicts coronary plaque volume in patients with coronary artery disease. Atherosclerosis. 2018 10; 277:34-41. PMID: 30170222.
    Citations:    Fields:    
  14. Alfaddagh A, Elajami TK, Saleh M, Elajami M, Bistrian BR, Welty FK. The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial. J Clin Lipidol. 2018 Jul - Aug; 12(4):937-947.e2. PMID: 29752179.
    Citations:    Fields:    
  15. Alfaddagh A, Elajami TK, Ashfaque H, Saleh M, Bistrian BR, Welty FK. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial. J Am Heart Assoc. 2017 Dec 15; 6(12). PMID: 29246960.
    Citations: 3     Fields:    Translation:Humans
  16. Elajami TK, Alfaddagh A, Lakshminarayan D, Soliman M, Chandnani M, Welty FK. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. J Am Heart Assoc. 2017 Jul 14; 6(7). PMID: 28710178.
    Citations:    Fields:    Translation:Humans
  17. Hachem A, Hariri E, Saoud P, Lteif C, Lteif L, Welty F. The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review. Curr Cardiol Rev. 2017; 13(4):274-282. PMID: 28782494.
    Citations:    Fields:    Translation:Humans
  18. Elajami TK, Giuseffi J, Avila MD, Hovnanians N, Mukamal KJ, Parikh N, Welty FK. Parity, coronary heart disease and mortality in the old order Amish. Atherosclerosis. 2016 11; 254:14-19. PMID: 27680773.
    Citations:    Fields:    Translation:Humans
  19. Lakshminarayan D, Elajami TK, Devabhaktuni S, Welty FK. Ischemic stroke in a young adult with extremely elevated lipoprotein(a): A case report and review of literature. J Clin Lipidol. 2016 Sep-Oct; 10(5):1266-71. PMID: 27678446.
    Citations:    Fields:    Translation:Humans
  20. Hauser TH, Salastekar N, Schaefer EJ, Desai T, Goldfine HL, Fowler KM, Weber GM, Welty F, Clouse M, Shoelson SE, Goldfine AB. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins. JAMA Cardiol. 2016 07 01; 1(4):413-23. PMID: 27438317.
    Citations: 5     Fields:    Translation:Humans
  21. Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J. 2016 08; 30(8):2792-801. PMID: 27121596.
    Citations: 21     Fields:    Translation:Humans
  22. Hartman ML, Goodson JM, Shi P, Vargas J, Yaskell T, Stephens D, Cugini M, Hasturk H, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Unhealthy Phenotype as Indicated by Salivary Biomarkers: Glucose, Insulin, VEGF-A, and IL-12p70 in Obese Kuwaiti Adolescents. J Obes. 2016; 2016:6860240. PMID: 27069678.
    Citations: 2     Fields:    Translation:Humans
  23. Regensteiner JG, Golden S, Huebschmann AG, Barrett-Connor E, Chang AY, Chyun D, Fox CS, Kim C, Mehta N, Reckelhoff JF, Reusch JE, Rexrode KM, Sumner AE, Welty FK, Wenger NK, Anton B. Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation. 2015 Dec 22; 132(25):2424-47. PMID: 26644329.
    Citations: 23     Fields:    Translation:Humans
  24. Welty FK, Lewis SJ, Friday KE, Cain VA, Anzalone DA. A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study. J Womens Health (Larchmt). 2016 Jan; 25(1):50-6. PMID: 26539650.
    Citations:    Fields:    Translation:Humans
  25. Shi P, Goodson JM, Hartman ML, Hasturk H, Yaskell T, Vargas J, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers. PLoS One. 2015; 10(9):e0138979. PMID: 26418011.
    Citations: 1     Fields:    Translation:Humans
  26. Hegele RA, Gidding SS, Ginsberg HN, McPherson R, Raal FJ, Rader DJ, Robinson JG, Welty FK. Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. Arterioscler Thromb Vasc Biol. 2015 Nov; 35(11):2269-80. PMID: 26376908.
    Citations: 9     Fields:    Translation:HumansCells
  27. Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016 Jan; 167(1):257-80. PMID: 26207884.
    Citations: 31     Fields:    Translation:Humans
  28. Singh V, Luthra S, Elajami TK, Welty FK. Resolution of NASH with weight loss documented by hepatic MRI. BMJ Case Rep. 2015 Jan 06; 2015. PMID: 25564638.
    Citations:    Fields:    Translation:Humans
  29. Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children. Diabetes Metab Syndr Obes. 2015; 8:9-15. PMID: 25565874.
    Citations: 6     
  30. Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 2015 Feb; 64(2):236-43. PMID: 25441251.
    Citations: 8     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  31. Goodson JM, Kantarci A, Hartman ML, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Metabolic disease risk in children by salivary biomarker analysis. PLoS One. 2014; 9(6):e98799. PMID: 24915044.
    Citations: 12     Fields:    Translation:Humans
  32. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol. 2014 Jun; 25(3):161-8. PMID: 24751931.
    Citations: 22     Fields:    Translation:Humans
  33. Jon AF, Cheema AR, Khan AN, Raptopoulos V, Hauser T, Nasser I, Welty FK, Karellas A, Clouse ME. Assessment of liver fat in an obese patient population using noncontrast CT fat percent index. Clin Imaging. 2014 May-Jun; 38(3):259-64. PMID: 24559751.
    Citations:    Fields:    Translation:Humans
  34. Welty FK. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep. 2013 Sep; 15(9):400. PMID: 23881582.
    Citations: 14     Fields:    Translation:Humans
  35. Khosa F, Khan AN, Nasir K, Bedayat A, Malik Z, Jon AF, Cheema AR, Clouse ME, Welty FK. Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA. Atherosclerosis. 2013 Feb; 226(2):428-32. PMID: 23287639.
    Citations: 2     Fields:    Translation:Humans
  36. Ooi EM, Lichtenstein AH, Millar JS, Diffenderfer MR, Lamon-Fava S, Rasmussen H, Welty FK, Barrett PH, Schaefer EJ. Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. J Lipid Res. 2012 Sep; 53(9):1958-67. PMID: 22773687.
    Citations: 6     Fields:    Translation:HumansAnimalsCTClinical Trials
  37. Ensrud K, LaCroix A, Thompson JR, Thompson DD, Eastell R, Reid DM, Vukicevic S, Cauley J, Barrett-Connor E, Armstrong R, Welty F, Cummings S. Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial. Circulation. 2010 Oct 26; 122(17):1716-24. PMID: 20937977.
    Citations: 5     Fields:    Translation:Humans
  38. Berger JE, Ahmann AJ, Balfour DC, Owens GS, Beltran R, Bush MA, Culpepper L, Owens GS, Ringel M, Welty FK. Treating to target: implementing an effective diabetes care paradigm for managed care. Am J Manag Care. 2010 Mar; 16 Suppl Treating:S4-35. PMID: 20297878.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  39. Ruan Y, Bridges JS, Kumar K, Raphael JA, Acharjee S, Welty FK. Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome. Clin Rheumatol. 2008 Dec; 27(12):1577-9. PMID: 18716731.
    Citations:    Fields:    Translation:Humans
  40. Clouse ME, Sabir A, Yam CS, Yoshimura N, Lin S, Welty F, Martinez-Clark P, Raptopoulos V. Measuring noncalcified coronary atherosclerotic plaque using voxel analysis with MDCT angiography: a pilot clinical study. AJR Am J Roentgenol. 2008 Jun; 190(6):1553-60. PMID: 18492906.
    Citations: 7     Fields:    Translation:Humans
  41. Nasca MM, Zhou JR, Welty FK. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol. 2008 Jul 01; 102(1):84-6. PMID: 18572041.
    Citations: 13     Fields:    Translation:Humans
  42. Acharjee S, Welty FK. Atorvastatin and cardiovascular risk in the elderly--patient considerations. Clin Interv Aging. 2008; 3(2):299-314. PMID: 18686752.
    Citations: 3     Fields:    Translation:Humans
  43. Wenger NK, Lewis SJ, Welty FK, Herrington DM, Bittner V. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Heart. 2008 Apr; 94(4):434-9. PMID: 18070940.
    Citations: 9     Fields:    Translation:Humans
  44. Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Cohn JS, Wilson A, Wolfe ML, Nartsupha C, Schaefer PM, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. J Lipid Res. 2008 Mar; 49(3):543-9. PMID: 18033754.
    Citations: 5     Fields:    Translation:Humans
  45. Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med. 2007 Jul 03; 147(1):1-9. PMID: 17606955.
    Citations: 24     Fields:    Translation:Humans
  46. Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ, Marsh JB. Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women. Metabolism. 2007 Jul; 56(7):910-4. PMID: 17570251.
    Citations: 2     Fields:    Translation:Humans
  47. Welty FK, Lee KS, Lew NS, Zhou JR. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med. 2007 May 28; 167(10):1060-7. PMID: 17533209.
    Citations: 29     Fields:    Translation:Humans
  48. Welty FK, Nasca MM, Lew NS, Gregoire S, Ruan Y. Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office. Am J Cardiol. 2007 Jul 01; 100(1):73-5. PMID: 17599444.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  49. Welty FK, Lee KS, Lew NS, Nasca M, Zhou JR. The association between soy nut consumption and decreased menopausal symptoms. J Womens Health (Larchmt). 2007 Apr; 16(3):361-9. PMID: 17439381.
    Citations: 6     Fields:    Translation:HumansAnimals
  50. Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Arterioscler Thromb Vasc Biol. 2006 Jun; 26(6):1350-6. PMID: 16574893.
    Citations: 18     Fields:    Translation:Humans
  51. Sommer U, Herscovitz H, Welty FK, Costello CE. LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J Lipid Res. 2006 Apr; 47(4):804-14. PMID: 16443931.
    Citations: 42     Fields:    Translation:Humans
  52. Lamon-Fava S, Postfai B, Diffenderfer M, DeLuca C, O'Connor J, Welty FK, Dolnikowski GG, Barrett PH, Schaefer EJ. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):385-91. PMID: 16339502.
    Citations: 9     Fields:    Translation:Humans
  53. Delichatsios HK, Welty FK. Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure. Curr Atheroscler Rep. 2005 Nov; 7(6):446-54. PMID: 16256002.
    Citations: 5     Fields:    Translation:Humans
  54. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation. 2005 Jul 26; 112(4):563-71. PMID: 16009795.
    Citations: 44     Fields:    Translation:Humans
  55. Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arterioscler Thromb Vasc Biol. 2005 Aug; 25(8):1691-6. PMID: 15933247.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  56. Dolnikowski GG, Marsh JB, Das SK, Welty FK. Stable isotopes in obesity research. Mass Spectrom Rev. 2005 May-Jun; 24(3):311-27. PMID: 15389849.
    Citations: 1     Fields:    Translation:Humans
  57. Brousseau ME, Diffenderfer MR, Millar JS, Nartsupha C, Asztalos BF, Welty FK, Wolfe ML, Rudling M, Björkhem I, Angelin B, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ. Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1057-64. PMID: 15761191.
    Citations: 46     Fields:    Translation:Humans
  58. Jenner JL, Seman LJ, Millar JS, Lamon-Fava S, Welty FK, Dolnikowski GG, Marcovina SM, Lichtenstein AH, Barrett PH, deLuca C, Schaefer EJ. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism. 2005 Mar; 54(3):361-9. PMID: 15736114.
    Citations: 12     Fields:    Translation:Humans
  59. Batista MC, Welty FK, Diffenderfer MR, Sarnak MJ, Schaefer EJ, Lamon-Fava S, Asztalos BF, Dolnikowski GG, Brousseau ME, Marsh JB. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism. 2004 Oct; 53(10):1255-61. PMID: 15375779.
    Citations: 20     Fields:    Translation:Humans
  60. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Arterioscler Thromb Vasc Biol. 2004 Sep; 24(9):1703-7. PMID: 15242863.
    Citations: 11     Fields:    Translation:Humans
  61. Welty FK. Preventing clinically evident coronary heart disease in the postmenopausal woman. Menopause. 2004 Jul-Aug; 11(4):484-94. PMID: 15243287.
    Citations: 2     Fields:    Translation:Humans
  62. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, Eckel RH, Schaefer EJ, Lichtenstein AH. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004 Jun; 24(6):1092-7. PMID: 15087307.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  63. Tilly-Kiesi M, Schaefer EJ, Knudsen P, Welty FK, Dolnikowski GG, Taskinen MR, Lichtenstein AH. Lipoprotein metabolism in subjects with hepatic lipase deficiency. Metabolism. 2004 Apr; 53(4):520-5. PMID: 15045702.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  64. Welty FK. Alternative hormone replacement regimens: is there a need for further clinical trials? Curr Opin Lipidol. 2003 Dec; 14(6):585-91. PMID: 14624135.
    Citations: 1     Fields:    Translation:Humans
  65. Welty FK. Nutrition and Women's Health Symposium. Introduction. J Womens Health (Larchmt). 2003 Mar; 12(2):105-8. PMID: 12737708.
    Citations:    Fields:    Translation:Humans
  66. Marsh JB, Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ. Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. Atherosclerosis. 2002 Jun; 162(2):227-44. PMID: 11996942.
    Citations: 8     Fields:    Translation:Humans
  67. Welty FK, Stuart E, O'Meara M, Huddleston J. Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol. Am J Cardiol. 2002 May 15; 89(10):1201-4. PMID: 12008176.
    Citations: 4     Fields:    Translation:Humans
  68. Schaefer EJ, Brousseau ME, Diffenderfer MR, Cohn JS, Welty FK, O'Connor J, Dolnikowski GG, Wang J, Hegele RA, Jones PJ. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis. 2001 Nov; 159(1):231-6. PMID: 11689226.
    Citations: 10     Fields:    Translation:Humans
  69. Welty FK, Guida KA, Andersen JJ. Donor splice-site mutation (210+1G_C) in the ApoB gene causes a very low level of ApoB-100 and LDL cholesterol. Arterioscler Thromb Vasc Biol. 2001 Nov; 21(11):1864-5. PMID: 11701479.
    Citations: 3     Fields:    Translation:HumansCells
  70. Welty FK. Women and cardiovascular risk. Am J Cardiol. 2001 Oct 11; 88(7B):48J-52J. PMID: 11595200.
    Citations: 4     Fields:    Translation:Humans
  71. Welty FK, Lewis SM, Kowalker W, Shubrooks SJ. Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal coronary angioplasty in women compared with men. Am J Cardiol. 2001 Sep 01; 88(5):473-7. PMID: 11524052.
    Citations: 2     Fields:    Translation:Humans
  72. Sun Z, Welty FK, Dolnikowski GG, Lichtenstein AH, Schaefer EJ. Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma. Am J Clin Nutr. 2001 Sep; 74(3):308-14. PMID: 11522553.
    Citations: 3     Fields:    Translation:Humans
  73. Sun Z, Lichtenstein AH, Dolnikowski GG, Welty FK, Schaefer EJ. Human apolipoprotein A-IV metabolism within triglyceride-rich lipoproteins and plasma. Atherosclerosis. 2001 Jun; 156(2):363-72. PMID: 11395033.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  74. Raggi P, Callister TQ, Davidson M, Welty FK, Bachmann GA, Laskey R, Pittman D, Kafonek S, Scott R. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial. Am Heart J. 2001 May; 141(5):722-6. PMID: 11320358.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  75. Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med. 2001 Feb 26; 161(4):514-22. PMID: 11252110.
    Citations: 5     Fields:    Translation:Humans
  76. Welty FK, Lichtenstein AH, Barrett PH, Jenner JL, Dolnikowski GG, Schaefer EJ. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Arterioscler Thromb Vasc Biol. 2000 Jul; 20(7):1807-10. PMID: 10894821.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  77. Marsh JB, Welty FK, Schaefer EJ. Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans. Curr Opin Lipidol. 2000 Jun; 11(3):261-6. PMID: 10882341.
    Citations: 7     Fields:    Translation:Humans
  78. Welty FK. Optimal management of non-ST segment elevation myocardial infarction remains unclear. J Am Coll Cardiol. 2000 Mar 15; 35(4):903-6. PMID: 10732886.
    Citations:    Fields:    Translation:Humans
  79. Velez-Carrasco W, Lichtenstein AH, Li Z, Dolnikowski GG, Lamon-Fava S, Welty FK, Schaefer EJ. Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3):801-6. PMID: 10712406.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  80. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol. 1999 Dec; 19(12):2966-74. PMID: 10591677.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  81. Vélez-Carrasco W, Lichtenstein AH, Barrett PH, Sun Z, Dolnikowski GG, Welty FK, Schaefer EJ. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J Lipid Res. 1999 Sep; 40(9):1695-700. PMID: 10484617.
    Citations: 5     Fields:    Translation:Humans
  82. Vélez-Carrasco W, Lichtenstein AH, Welty FK, Li Z, Lamon-Fava S, Dolnikowski GG, Schaefer EJ. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion. Arterioscler Thromb Vasc Biol. 1999 Apr; 19(4):918-24. PMID: 10195918.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  83. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PW, Schaefer EJ. Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population. Arterioscler Thromb Vasc Biol. 1998 Nov; 18(11):1745-51. PMID: 9812913.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  84. Gebara OC, Mittleman MA, Walsh BW, Lipinska I, Welty FK, Bellotti G, Muller JE, Sacks FK, Tofler GH. Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart. 1998 Sep; 80(3):235-9. PMID: 9875081.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  85. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. J Lipid Res. 1997 Aug; 38(8):1535-43. PMID: 9300775.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  86. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Arterioscler Thromb Vasc Biol. 1997 May; 17(5):881-8. PMID: 9157951.
    Citations: 7     Fields:    Translation:Humans
  87. Welty FK, Mittleman MA, Wilson PW, Sutherland PA, Matheney TH, Lipinska I, Muller JE, Levy D, Tofler GH. Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population. Circulation. 1997 Feb 18; 95(4):825-30. PMID: 9054738.
    Citations: 4     Fields:    Translation:Humans
  88. Welty FK, Mittleman MA, Lewis SM, Kowalker WL, Healy RW, Shubrooks SJ, Muller JE. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%. Circulation. 1996 Apr 15; 93(8):1496-501. PMID: 8608616.
    Citations: 5     Fields:    Translation:Humans
  89. Welty FK. Who Should Receive Hormone Replacement Therapy? J Thromb Thrombolysis. 1996; 3(1):13-21. PMID: 10608035.
    Citations:    Fields:    
  90. Welty FK, Seman L, Yen FT. Purification of the apolipoprotein B-67-containing low density lipoprotein particle and its affinity for the low density lipoprotein receptor. J Lipid Res. 1995 Dec; 36(12):2622-9. PMID: 8847488.
    Citations: 5     Fields:    Translation:HumansCells
  91. Welty FK, Ordovas J, Schaefer EJ, Wilson PW, Young SG. Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels. Circulation. 1995 Oct 15; 92(8):2036-40. PMID: 7554178.
    Citations: 4     Fields:    Translation:HumansCells
  92. Welty FK, Mittleman MA, Lewis SM, Healy RW, Shubrooks SJ, Muller JE. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol. 1995 Sep 01; 76(7):431-5. PMID: 7653439.
    Citations: 5     Fields:    Translation:Humans
  93. Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995 Apr 01; 91(7):1952-8. PMID: 7895352.
    Citations: 31     Fields:    Translation:Humans
  94. Welty FK, Mittleman MA, Healy RW, Muller JE, Shubrooks SJ. Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. J Am Coll Cardiol. 1994 Jan; 23(1):35-9. PMID: 8277093.
    Citations: 3     Fields:    Translation:Humans
  95. Welty FK, McLeod GX, Ezratty C, Healy RW, Karchmer AW. Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis. 1992 Nov; 15(5):858-60. PMID: 1445984.
    Citations: 9     Fields:    Translation:HumansAnimals
  96. Weinrauch LA, D'Elia JA, Monaco AP, Gleason RE, Welty F, Nishan PC, Nesto RW. Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med. 1992 Jul; 93(1):19-28. PMID: 1626568.
    Citations: 6     Fields:    Translation:Humans
  97. Siu SC, Kowalchuk GJ, Welty FK, Benotti PN, Lewis SM. Intra-aortic balloon counterpulsation support in the high-risk cardiac patient undergoing urgent noncardiac surgery. Chest. 1991 Jun; 99(6):1342-5. PMID: 2036814.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  98. Welty FK, Hubl ST, Pierotti VR, Young SG. A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia. J Clin Invest. 1991 May; 87(5):1748-54. PMID: 2022744.
    Citations: 6     Fields:    Translation:HumansCells
  99. Welty FK, Wood HG. Purification of the "corrinoid" enzyme involved in the synthesis of acetate by Clostridium thermoaceticum. J Biol Chem. 1978 Aug 25; 253(16):5832-8. PMID: 670234.
    Citations: 8     Fields:    Translation:Cells
  100. Welty FK, Smith KL, Schanbacher FL. Lactoferrin concentration during involution of the bovine mammary gland. J Dairy Sci. 1976 Feb; 59(2):224-31. PMID: 1249287.
    Citations: 7     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Welty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (407)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.